BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 35399924)

  • 21. Primary aldosteronism concurrent with subclinical Cushing's syndrome: a case report and review of the literature.
    Zhang Y; Tan J; Yang Q; Du Z; Yang S; He W; Song Y; Hu J; Yang Y; Li Q; Zhang Y; He Y; Cheng Q;
    J Med Case Rep; 2020 Feb; 14(1):32. PubMed ID: 32075693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case Report: Nodule Development From Subcapsular Aldosterone-Producing Cell Clusters Causes Hyperaldosteronism.
    Nishimoto K; Seki T; Kurihara I; Yokota K; Omura M; Nishikawa T; Shibata H; Kosaka T; Oya M; Suematsu M; Mukai K
    J Clin Endocrinol Metab; 2016 Jan; 101(1):6-9. PubMed ID: 26580238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Dissection of Primary Aldosteronism in a Patient With MEN1 and Ipsilateral Adrenocortical Carcinoma and Adenoma.
    Parisien-La Salle S; Corbeil G; El-Haffaf Z; Duranceau C; Latour M; Karakiewicz PI; Lacroix A; Bourdeau I
    J Clin Endocrinol Metab; 2022 Dec; 108(1):26-32. PubMed ID: 36179244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas.
    Williams TA; Monticone S; Schack VR; Stindl J; Burrello J; Buffolo F; Annaratone L; Castellano I; Beuschlein F; Reincke M; Lucatello B; Ronconi V; Fallo F; Bernini G; Maccario M; Giacchetti G; Veglio F; Warth R; Vilsen B; Mulatero P
    Hypertension; 2014 Jan; 63(1):188-95. PubMed ID: 24082052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Novel Somatic Deletion Mutation of ATP2B3 in Aldosterone-Producing Adenoma.
    Murakami M; Yoshimoto T; Minami I; Bouchi R; Tsuchiya K; Hashimoto K; Izumiyama H; Fujii Y; Endo T; Akashi T; Nishimoto K; Mukai K; Kihara K; Ogawa Y
    Endocr Pathol; 2015 Dec; 26(4):328-33. PubMed ID: 26481629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas.
    Nanba K; Rainey WE
    Eur J Endocrinol; 2021 May; 185(1):R1-R11. PubMed ID: 33900205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical Outcomes of Aldosterone-Producing Adenoma on the Basis of the Histopathological Findings.
    Wang H; Wang F; Zhang Y; Wen J; Dong D; Chang X; Sun H; Ma X; Cui Y; Chen S; Lu L; Ren W; Tong A; Li Y
    Front Endocrinol (Lausanne); 2021; 12():663096. PubMed ID: 34552553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro release of aldosterone and cortisol in human adrenal adenomas correlates to mRNA expression of steroidogenic enzymes for genes CYP11B2 and CYP17.
    Enberg U; Farnebo LO; Wedell A; Gröndal S; Thorén M; Grimelius L; Kjellman M; Bäckdahl M; Hamberger B
    World J Surg; 2001 Jul; 25(7):957-66. PubMed ID: 11572038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary aldosteronism caused by a pI157S somatic
    Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
    Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
    Pitsava G; Faucz FR; Stratakis CA; Hannah-Shmouni F
    Curr Cardiol Rep; 2022 Sep; 24(9):1189-1195. PubMed ID: 35841527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Concordance Between Imaging and Adrenal Vein Sampling Varies With Aldosterone-Driver Somatic Mutation.
    Wannachalee T; Caoili E; Nanba K; Nanba A; Rainey WE; Shields JJ; Turcu AF
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3628-37. PubMed ID: 32717082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma.
    Yoshii Y; Oki K; Gomez-Sanchez CE; Ohno H; Itcho K; Kobuke K; Yoneda M
    Hypertension; 2016 Dec; 68(6):1432-1437. PubMed ID: 27754862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
    Kuppusamy M; Caroccia B; Stindl J; Bandulik S; Lenzini L; Gioco F; Fishman V; Zanotti G; Gomez-Sanchez C; Bader M; Warth R; Rossi GP
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1765-73. PubMed ID: 25057880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic analyses of aldosterone-producing adenoma with hypercortisolemia.
    Kometani M; Yoneda T; Demura M; Aono D; Gondoh Y; Karashima S; Nishimoto K; Yasuda M; Horike SI; Takeda Y
    Steroids; 2019 Nov; 151():108470. PubMed ID: 31400391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Primary aldosteronism: new insights into familial forms].
    van den Meiracker AH; van der Linde AA; Claahsen van der Grinten HL; Danser AH; Deinum J
    Ned Tijdschr Geneeskd; 2015; 159():A8932. PubMed ID: 26420144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Heterogeneity in Aldosterone-Producing Adenomas.
    Nanba K; Chen AX; Omata K; Vinco M; Giordano TJ; Else T; Hammer GD; Tomlins SA; Rainey WE
    J Clin Endocrinol Metab; 2016 Mar; 101(3):999-1007. PubMed ID: 26765578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathological diagnosis of primary aldosteronism using CYP11B2 immunohistochemistry.
    Nanba K; Tsuiki M; Sawai K; Mukai K; Nishimoto K; Usui T; Tagami T; Okuno H; Yamamoto T; Shimatsu A; Katabami T; Okumura A; Kawa G; Tanabe A; Naruse M
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1567-74. PubMed ID: 23443813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrolides for KCNJ5-mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism.
    Maiolino G; Ceolotto G; Battistel M; Barbiero G; Cesari M; Amar L; Caroccia B; Padrini R; Azizi M; Rossi GP
    Blood Press; 2018 Aug; 27(4):200-205. PubMed ID: 29409357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Aldosteronism: Spatial Multiomics Mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing Adenomas.
    Gong S; Sun N; Meyer LS; Tetti M; Koupourtidou C; Krebs S; Masserdotti G; Blum H; Rainey WE; Reincke M; Walch A; Williams TA
    Hypertension; 2023 Jul; 80(7):1555-1567. PubMed ID: 37125608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 18-Oxocortisol: A journey.
    Gomez-Sanchez CE; Gomez-Sanchez EP
    J Steroid Biochem Mol Biol; 2023 Jun; 230():106291. PubMed ID: 36921907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.